Chakos Kaitlin, Pezley Lacey, Bryner Alyssa, Czyzewski Ola, Corral Jennifer, Marquina Vanessa, Gadi Vijayakrishna, Ganschow Pamela, Tussing-Humphreys Lisa, Gabel Kelsey
Department of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL 60612, United States.
University of Illinois Cancer Center, Chicago, IL 60612, United States.
Nutr Rev. 2025 Mar 1;83(3):479-502. doi: 10.1093/nutrit/nuae109.
Breast cancer is a significant public health challenge, with 290 000 new cases annually and significant healthcare costs. Treatment advancements have led to improvements in survival, but common adverse effects include weight gain, fatigue, nausea, and taste changes, decreasing quality of life.
This review aims to assess the impact of diet and lifestyle interventions during primary treatment for breast cancer and their effects on body weight, body composition, treatment-related adverse outcomes, and patient-reported quality of life.
A search of PubMed, CINAHL, and EMBASE conducted through May 10, 2023, identified 31 publications describing 27 interventions including diet or diet plus exercise. The Cochrane Risk of Bias tool assessed the quality of publications.
The findings suggest that whole foods, aerobic and strength-training exercises, and intermittent fasting during treatment may improve body weight and composition, treatment-related outcomes, and quality of life. Limitations include variation in study duration, small sample sizes, and limited sociodemographic data.
Improvements seen with increased diet quality and reduced caloric intake, with or without exercise, challenge current standard-of-care recommendations during treatment for breast cancer. While there is a need for additional research, healthcare teams can confidently promote healthy diets and exercise during primary treatment for breast cancer to manage weight and improve treatment-related side effects and quality of life.
PROSPERO registration no. 42023425613.
乳腺癌是一项重大的公共卫生挑战,每年有29万新发病例,医疗成本高昂。治疗进展提高了生存率,但常见的不良反应包括体重增加、疲劳、恶心和味觉改变,降低了生活质量。
本综述旨在评估乳腺癌初次治疗期间饮食和生活方式干预的影响及其对体重、身体成分、治疗相关不良结局和患者报告的生活质量的影响。
通过检索截至2023年5月10日的PubMed、CINAHL和EMBASE,确定了31篇描述27项干预措施的出版物,包括饮食或饮食加运动。Cochrane偏倚风险工具评估了出版物的质量。
研究结果表明,治疗期间的全食物、有氧运动和力量训练以及间歇性禁食可能改善体重和身体成分、治疗相关结局和生活质量。局限性包括研究持续时间的差异、样本量小以及社会人口统计学数据有限。
饮食质量提高和热量摄入减少(无论是否进行运动)所带来的改善,对乳腺癌治疗期间当前的护理标准建议提出了挑战。虽然需要更多的研究,但医疗团队可以在乳腺癌初次治疗期间自信地推广健康饮食和运动,以控制体重并改善治疗相关的副作用和生活质量。
PROSPERO注册号42023425613。